The residents of developing countries need pharmaceutical products at least as much as the residents of developed countries.

Many new drugs imported by developed countries for non-communicable diseases, cardiovascular diseases, and communicable diseases are patent protected and are not allowed to be made anywhere else without permission, which makes the availability of important drugs difficult in developing countries.

Using a sound framework to support local production of pharmaceutical products could go a long way in saving many lives and catalyzing economic development, and capturing more fully the benefits of liberalized trade and regional integration. in developing countries.